Isentress Tablet, Film Coated
Product Images NDC 68071-2113

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Isentress (NDC 68071-2113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 2113 6

This is a description of Isentress 400mg tablets from NuCare Pharmaceuticals, Inc. The tablets come in an oval shape with a pink color and are marked with "227" on one side and "E" on the other. Each tablet contains 434.4mg Raltegravir and Potassium, equivalent to 400mg Raltegravir. The lot# is 00000, and the expiry date is 00-00. It is advised to call a doctor for medical advice about side effects, and the product is required to be kept out of reach of children and stored at a controlled temperature of 68-77°F.*

FDA Label Image

Chemical Structure (Isentress 01)

FDA Label Image

Figure A (Isentress 02)

The text contains information about a product that includes two mixing cups and 60 foil packets of ISENTRESS medication for oral suspension. Figure A may provide further details about the product.*

FDA Label Image

Figure B (Isentress 03)

FDA Label Image

Figure C (Isentress 04)

FDA Label Image

Figure D (Isentress 05)

FDA Label Image

Figure E (Isentress 06)

FDA Label Image

Figure F (Isentress 07)

FDA Label Image

Figure G (Isentress 08)

FDA Label Image

Figure H (Isentress 09)

FDA Label Image

Figure I (Isentress 10)

FDA Label Image

Figure J (Isentress 11)

FDA Label Image

Figure K (Isentress 12)

FDA Label Image

Figure L (Isentress 13)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.